JPH061757A - Production of optically active alpha-methylbenzylamine - Google Patents
Production of optically active alpha-methylbenzylamineInfo
- Publication number
- JPH061757A JPH061757A JP15835692A JP15835692A JPH061757A JP H061757 A JPH061757 A JP H061757A JP 15835692 A JP15835692 A JP 15835692A JP 15835692 A JP15835692 A JP 15835692A JP H061757 A JPH061757 A JP H061757A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- methylbenzylamine
- optically active
- formula
- methylbenzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 61
- 239000013078 crystal Substances 0.000 claims abstract description 38
- NXLACVVNHYIYJN-UHFFFAOYSA-N 1-phenyl-n-(1-phenylethyl)ethanamine Chemical compound C=1C=CC=CC=1C(C)NC(C)C1=CC=CC=C1 NXLACVVNHYIYJN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 230000003287 optical effect Effects 0.000 claims abstract description 19
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims abstract description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 10
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims abstract description 8
- 229960002510 mandelic acid Drugs 0.000 claims abstract description 8
- 239000012736 aqueous medium Substances 0.000 claims abstract description 6
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 5
- 150000007524 organic acids Chemical class 0.000 claims abstract description 5
- 150000003141 primary amines Chemical class 0.000 claims abstract description 5
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 4
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 25
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 claims description 7
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 claims description 6
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 claims description 5
- IWYDHOAUDWTVEP-SSDOTTSWSA-M (R)-mandelate Chemical compound [O-]C(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-M 0.000 claims description 4
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 claims description 2
- IWYDHOAUDWTVEP-ZETCQYMHSA-M (S)-mandelate Chemical compound [O-]C(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-M 0.000 claims 1
- 238000000151 deposition Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract description 6
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 abstract description 4
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 abstract description 3
- 235000019270 ammonium chloride Nutrition 0.000 abstract description 3
- 239000004323 potassium nitrate Substances 0.000 abstract description 2
- 235000010333 potassium nitrate Nutrition 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241000276425 Xiphophorus maculatus Species 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 150000001412 amines Chemical class 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- ZBQCLJZOKDRAOW-DTPOWOMPSA-N (1r)-1-phenyl-n-[(1r)-1-phenylethyl]ethanamine;hydrochloride Chemical compound Cl.C1([C@@H](C)N[C@H](C)C=2C=CC=CC=2)=CC=CC=C1 ZBQCLJZOKDRAOW-DTPOWOMPSA-N 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- YEHGSOZIZRABBU-UHFFFAOYSA-N 1-phenylethanamine;hydrochloride Chemical compound [Cl-].CC([NH3+])C1=CC=CC=C1 YEHGSOZIZRABBU-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003631 expected effect Effects 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- -1 that is Chemical compound 0.000 description 2
- NXLACVVNHYIYJN-ZIAGYGMSSA-N (1r)-1-phenyl-n-[(1r)-1-phenylethyl]ethanamine Chemical compound C1([C@@H](C)N[C@H](C)C=2C=CC=CC=2)=CC=CC=C1 NXLACVVNHYIYJN-ZIAGYGMSSA-N 0.000 description 1
- TYJQMFZZCANDIQ-BTQNPOSSSA-N (1r)-n-benzyl-1-phenylethanamine;hydrochloride Chemical compound Cl.N([C@H](C)C=1C=CC=CC=1)CC1=CC=CC=C1 TYJQMFZZCANDIQ-BTQNPOSSSA-N 0.000 description 1
- NXLACVVNHYIYJN-KBPBESRZSA-N (1s)-1-phenyl-n-[(1s)-1-phenylethyl]ethanamine Chemical compound C1([C@H](C)N[C@@H](C)C=2C=CC=CC=2)=CC=CC=C1 NXLACVVNHYIYJN-KBPBESRZSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- OXVXWUDYARFPLN-UHFFFAOYSA-N ethylazanium;hydron;sulfate Chemical compound CC[NH3+].OS([O-])(=O)=O OXVXWUDYARFPLN-UHFFFAOYSA-N 0.000 description 1
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- ZYZHMSJNPCYUTB-UHFFFAOYSA-N n-benzyl-1-phenylethanamine Chemical compound C=1C=CC=CC=1C(C)NCC1=CC=CC=C1 ZYZHMSJNPCYUTB-UHFFFAOYSA-N 0.000 description 1
- IYPATBNFQGRBSH-UHFFFAOYSA-N nitric acid;phenylmethanamine Chemical compound O[N+]([O-])=O.NCC1=CC=CC=C1 IYPATBNFQGRBSH-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- CBPYOHALYYGNOE-UHFFFAOYSA-M potassium;3,5-dinitrobenzoate Chemical compound [K+].[O-]C(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 CBPYOHALYYGNOE-UHFFFAOYSA-M 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000007785 strong electrolyte Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、(RS)−α−メチル
ベンジルアミンからジアステレオマー法により(R)−
または(S)−α−メチルベンジルアミンを製造する方
法の改良に関する。 本発明の方法により、難溶性のジ
アステレオマー塩が濾過の容易な結晶形態で得られる。The present invention relates to (R)-by the diastereomer method from (RS) -α-methylbenzylamine.
Alternatively, it relates to an improvement in the method for producing (S) -α-methylbenzylamine. The process according to the invention gives sparingly soluble diastereomeric salts in crystalline form which are easy to filter.
【0002】[0002]
【従来の技術】光学活性な化合物の需要が年々増加し、
その応用分野は医薬や農薬ばかりでなく、強誘電性液晶
材料にまで広がっている。 それとともに光学純度に対
する要求もきびしくなり、とくに医薬、農薬の分野で
は、不要な対掌体は不純物とみなして極力排除する傾向
にある。 従って、所望の対掌体を高い光学純度をもっ
て、工業的に有利に製造する技術の開発が望まれてい
る。2. Description of the Related Art The demand for optically active compounds is increasing year by year,
Its fields of application are not limited to pharmaceuticals and agricultural chemicals, but also to ferroelectric liquid crystal materials. At the same time, the demand for optical purity is becoming stricter, and especially in the fields of medicine and agricultural chemicals, unnecessary enantiomers tend to be regarded as impurities and eliminated as much as possible. Therefore, it is desired to develop a technique for industrially producing a desired enantiomer with high optical purity.
【0003】工業的な実施に適する光学分割技術のひと
つとして、ジアステレオマー法がある。 この方法は、
よく知られているとおり、目的物のラセミ体に光学活性
な分割剤を作用させて所望の対掌体と分割剤とのジアス
テレオマーを難溶性塩として析出させ、固液分離したの
ち分解して、光学活性体を取得することからなる。The diastereomer method is one of the optical resolution techniques suitable for industrial implementation. This method
As is well known, an optically active resolving agent is allowed to act on a racemic compound of interest to precipitate a diastereomer of a desired enantiomer and a resolving agent as a sparingly soluble salt, followed by solid-liquid separation and decomposition. And obtaining an optically active substance.
【0004】この過程で得られる難溶性塩の形態はさま
ざまである。 結晶はもちろん大きい方がよいが、見掛
上大きくても薄い鱗片状であったり、長く薄い板状であ
ったりすると、遠心分離機にかけたときに結晶が遠心力
に対し直角の方向に配列して重なり合う結果、母液の濾
過性が悪くなるばかりか、洗浄性をも損なうことが多
い。 その結果、得られる製品の光学純度が低くなる。
それゆえ、難溶性ジアステレオマー塩の結晶を濾過容
易な形態で得ることは、光学活性な化合物の製造におい
て重要である。There are various forms of poorly soluble salts obtained in this process. Of course, it is better for the crystals to be large, but if they are apparently large and have a thin scaly shape or a long thin plate shape, the crystals will be aligned in a direction perpendicular to the centrifugal force when applied to a centrifuge. As a result of the overlap, the filterability of the mother liquor is often deteriorated, and the washability is often impaired. As a result, the optical purity of the obtained product becomes low.
Therefore, obtaining crystals of a poorly soluble diastereomeric salt in an easily filterable form is important in the production of optically active compounds.
【0005】発明者らのひとりは、ラセミ体のα−フェ
ニルエチルアミンすなわちα−メチルベンジルアミンか
ら、光学活性マンデル酸を分割剤として使用するジアス
テレオマー法により光学活性体を製造する技術を確立
し、すでに提案した(特公平2−4581号)。One of the inventors has established a technique for producing an optically active substance from racemic α-phenylethylamine, that is, α-methylbenzylamine, by a diastereomer method using optically active mandelic acid as a resolving agent. , Already proposed (Japanese Patent Publication No. 2-4581).
【0006】その技術の工業的実施に当っても、上述し
た問題がある。 α−メチルベンジルアミン・マンデル
酸塩の難溶性ジアステレオマー塩結晶は、一般に薄く長
い六角板状であって、濾過性がよくない。Even in the industrial implementation of the technique, there are the above-mentioned problems. The sparingly soluble diastereomeric salt crystals of α-methylbenzylamine mandelate are generally thin and long hexagonal plates and have poor filterability.
【0007】[0007]
【発明が解決しようとする課題】本発明の目的は、ラセ
ミ体のα−メチルベンジルアミンから光学活性マンデル
酸を分割剤として使用するジアステレオマー法により光
学活性体を製造する方法を、工業的に有利なように改良
し、難溶性ジアステレオマー塩の結晶形態を濾過が容易
なものにして実施する方法を提供することにある。The object of the present invention is to provide a method for producing an optically active substance from a racemic α-methylbenzylamine by a diastereomeric method using an optically active mandelic acid as a resolving agent. It is an object of the present invention to provide a method for carrying out the method, in which the crystalline form of the poorly soluble diastereomeric salt is easily filtered, which is improved.
【0008】[0008]
【課題を解決するための手段】本発明の光学活性α−メ
チルベンジルアミンの製造方法は、上述した(RS)−
α−メチルベンジルアミンからジアステレオマー法によ
り(R)−または(S)−α−メチルベンジルアミンを
製造する方法において、水性媒体中で、(RS)−α−
メチルベンジルアミンに対し、式(I)であらわされる
ビス(α−メチルベンジル)アミンThe method for producing an optically active α-methylbenzylamine of the present invention comprises the above-mentioned (RS)-
In the method for producing (R)-or (S) -α-methylbenzylamine from α-methylbenzylamine by the diastereomer method, (RS) -α-
Bis (α-methylbenzyl) amine represented by the formula (I) with respect to methylbenzylamine
【0009】[0009]
【化3】 [Chemical 3]
【0010】ならびに、アンモニアもしくは一級アミン
の無機酸もしくは有機酸の塩類および(または)水溶性
無機塩類の存在下に、分割剤として光学活性マンデル酸
を作用させ、式(II)であらわされる難溶性の光学活性
ジアステレオマー塩In addition, an optically active mandelic acid is allowed to act as a resolving agent in the presence of a salt of an inorganic acid or an organic acid of ammonia or a primary amine and / or a water-soluble inorganic salt, and is hardly soluble as represented by the formula (II). Optically active diastereomeric salts of
【0011】[0011]
【化4】 [Chemical 4]
【0012】(式中、*は不斉炭素原子をあらわす。)
を濾過容易な結晶として析出させることを特徴とする。(In the formula, * represents an asymmetric carbon atom.)
Is precipitated as crystals that can be easily filtered.
【0013】上記の製造方法において(R)−α−メチ
ルベンジルアミンを取得しようとする場合には、光学分
割剤として(R)−マンデル酸を使用し、式(I)であ
らわされるビス(α−メチルベンジル)アミンとして、
立体配置が(R,R)または(R,S)であるもの、好
ましくは前者を存在させ、式(II)であらわされる難溶
性ジアステレオマー塩として(R)−α−メチルベンジ
ルアミン・(R)−マンデル酸塩を形成させる。In order to obtain (R) -α-methylbenzylamine in the above production method, (R) -mandelic acid is used as an optical resolving agent, and bis (α) represented by the formula (I) is used. -Methylbenzyl) amine,
Those having a configuration of (R, R) or (R, S), preferably in the presence of the former, as a sparingly soluble diastereomeric salt represented by the formula (II), (R) -α-methylbenzylamine. ( R) -mandelate salt is formed.
【0014】一方、(S)−α−メチルベンジルアミンを
取得しようとする場合には、光学分割剤として(S)−
マンデル酸を使用し、式(I)であらわされるビス(α
−メチルベンジル)アミンとして、立体配置が(S,
S)または(R,S)であるもの、好ましくは前者を存
在させ、式(II)であらわされる難溶性ジアステレオマ
ー塩として(S)−α−メチルベンジルアミン・(S)
−マンデル酸塩を形成させる。 要するに、ビス(α−
メチルベンジル)アミンとして、その立体配置の少なく
とも一つ、好ましくは二つが、析出させようとする難溶
性ジアステレオマー塩を構成するα−メチルベンジルア
ミンの立体配置と同じであるものを使用する。On the other hand, when an attempt is made to obtain (S) -α-methylbenzylamine, (S) -as an optical resolving agent.
Using mandelic acid, bis (α) represented by the formula (I)
-Methylbenzyl) amine has the configuration (S,
S) or (R, S), preferably in the presence of the former, as the sparingly soluble diastereomeric salt represented by formula (II), (S) -α-methylbenzylamine. (S)
Form a mandelate salt. In short, bis (α-
As the methylbenzyl) amine, one having at least one of the configurations, preferably two, which is the same as the configuration of α-methylbenzylamine constituting the sparingly soluble diastereomeric salt to be precipitated is used.
【0015】ビス(αーメチルベンジル)アミンの合成
法は、M.B Eleveldら,J.Org.Chem.,51(19),3
635(1986)に記載されている。 ただし、この
報告は(S、S)体を目的とするものである。A method for synthesizing bis (α-methylbenzyl) amine is described by MB Eleveld et al., J. Org. Chem., 51 (19), 3
635 (1986). However, this report is intended for the (S, S) form.
【0016】難溶性ジアステルオマー塩の再結晶工程に
おいても、上記のようなビス(αーメチルベンジル)ア
ミンを添加し、前記の有機塩類または無機塩類が存在す
るという条件下に操作すれば、光学分割反応の工程と同
様にジアステレオマー塩の結晶が、厚い六角板状晶また
は菱形晶として得られ、固液分離が容易であるという利
益を、ここでも享受できる。Also in the recrystallization step of the poorly soluble diasteromeric salt, optical resolution can be achieved by adding bis (α-methylbenzyl) amine as described above and operating under the condition that the above organic salt or inorganic salt is present. Similar to the reaction step, crystals of the diastereomeric salt are obtained as thick hexagonal plate crystals or rhomboid crystals, and the advantage of easy solid-liquid separation can be enjoyed here as well.
【0017】[0017]
【作用】光学活性体の結晶の晶癖が特定の添加剤により
変化することは、ある種のアミノ酸類に関して知られて
いた〔Lahavら、Nature,296巻,p.2
1(1982)〕。 しかし、α−メチルベンジルアミ
ンの光学分割に関しては、難溶性ジアステレオマー塩の
晶癖を添加剤により変化させ得る可能性すら考えられて
いなかった。 従って、前記式(I)であらわされるビ
ス(α−メチルベンジル)アミンと特定の塩類との存在
下にジアステレオマー法を実施したとき、結晶形態が濾
過性のよい厚い六角晶や菱形晶になることは、本発明者
らがはじめて見出した事実である。The fact that the crystal habit of crystals of an optically active substance is changed by a specific additive has been known for certain amino acids [Lahav et al., Nature, 296, p. Two
1 (1982)]. However, regarding the optical resolution of α-methylbenzylamine, it was not considered that the crystal habit of the sparingly soluble diastereomeric salt could be changed by an additive. Therefore, when the diastereomer method is carried out in the presence of the bis (α-methylbenzyl) amine represented by the formula (I) and a specific salt, the crystal form becomes a thick hexagonal crystal or rhombic crystal with good filterability. That is the fact that the present inventors have found for the first time.
【0018】ビス(α−メチルベンジル)アミンは、前
記したように、目的物に応じて、立体配置が(R,R)ま
たは(S,S)を使用するのが有利であり、難溶性ジアス
テレオマー塩に対して重量で0.005%以上あれば有
効である。 (R,S)または(S,R)であらわされ
るものは目的物がどちらであっても使用できるが、難溶
性ジアステレオマー塩に対して0.2モル%程度の存在
を必要とする。 ビス(α−メチルベンジル)アミンが
目的物と立体配置に関して同じ構成部分をもっていない
場合は、1重量%を添加しても、期待した効果を得るこ
とができない。As described above, the bis (α-methylbenzyl) amine is advantageous in that the steric configuration is (R, R) or (S, S) depending on the intended product. It is effective if the weight is 0.005% or more based on the stereomeric salt. What is represented by (R, S) or (S, R) can be used regardless of the intended product, but it needs to be present in an amount of about 0.2 mol% based on the sparingly soluble diastereomeric salt. When bis (α-methylbenzyl) amine does not have the same constitutional portion with respect to the target compound in terms of configuration, the expected effect cannot be obtained even if 1% by weight is added.
【0019】ビス(α−メチルベンジル)アミンに代え
てベンジルアミン、エチルアミン、ジエチルアミン、あ
るいはN−ベンジル−α−メチルベンジルアミンなどを
加えても難溶性ジアステレオマー塩の結晶形態の変化は
認められない。 このことと上記の事実とから、本発明
の効果の発現に関して、ビス(α−メチルベンジル)ア
ミンが立体選択的に作用していることがうかがわれる。Even if benzylamine, ethylamine, diethylamine, N-benzyl-α-methylbenzylamine or the like is added instead of bis (α-methylbenzyl) amine, a change in crystal form of the hardly soluble diastereomer salt is recognized. Absent. From this fact and the above fact, it can be seen that bis (α-methylbenzyl) amine acts in a stereoselective manner with respect to the manifestation of the effect of the present invention.
【0020】二級アミンであるビス(α−メチルベンジ
ル)アミンは、水性媒体に対する溶解度が小さいため、
反応系に(RS)−α−メチルベンジルアミンとともに
加えて、塩酸、硫酸あるいは酢酸などで中和して溶解度
を高めるか、またははじめから鉱酸塩の形で加えるなど
するとよい。Since the secondary amine bis (α-methylbenzyl) amine has a low solubility in an aqueous medium,
It may be added to the reaction system together with (RS) -α-methylbenzylamine and neutralized with hydrochloric acid, sulfuric acid or acetic acid to increase the solubility, or added in the form of a mineral acid salt from the beginning.
【0021】ビス(α−メチルベンジル)アミンととも
に存在させる塩類のひとつのグループは、前記したよう
に、アンモニアもしくは一級アミンの無機酸もしくは有
機酸の塩類、たとえば塩化アンモニウム、酢酸アンモニ
ウム、エチルアミン硫酸塩、ベンジルアミン硝酸塩など
である。 α−メチルベンジルアミン塩酸塩も有効であ
るから、後記する例に示すように、光学分割の対象とす
る(RS)−α−メチルベンジルアミンの一部を塩酸で
中和した形で反応系に存在させ、その分を差し引いた量
の分割剤すなわち光学活性マンデル酸を作用させること
によっても、同じ効果を挙げることができる。One group of salts present with bis (α-methylbenzyl) amine is, as mentioned above, salts of inorganic or organic acids of ammonia or primary amines such as ammonium chloride, ammonium acetate, ethylamine sulphate, Examples include benzylamine nitrate. Since α-methylbenzylamine hydrochloride is also effective, a part of (RS) -α-methylbenzylamine to be subjected to optical resolution is neutralized with hydrochloric acid to form a reaction system as shown in the example described later. The same effect can be obtained also by allowing the amount of the resolving agent, ie, the optically active mandelic acid, to exist and subtract the amount of the resolving agent.
【0022】いまひとつのグループは、塩化ナトリウ
ム、硝酸カリウム、塩化マグネシウム、塩化カルシウム
などの、水に対する溶解度の高い強電解質の塩類であ
る。Another group is salts of strong electrolytes having high solubility in water, such as sodium chloride, potassium nitrate, magnesium chloride and calcium chloride.
【0023】どちらのグループの塩も、グループ内の2
種以上、あるいはグループ間の2種以上を併用してよい
ことはもちろんである。 添加量は広い範囲から選ぶこ
とができ、生成させようとする難溶性ジアステレオマー
塩に対して1〜500モル%、好適には5〜300モル
%を使用する。Both groups of salt are
Of course, two or more species or two or more species between groups may be used in combination. The addition amount can be selected from a wide range, and it is used in an amount of 1 to 500 mol%, preferably 5 to 300 mol% based on the hardly soluble diastereomer salt to be produced.
【0024】反応を行なう水性媒体は、水または水を主
体としてこれにメタノール、エタノール、あるいはアセ
トンなどの有機溶剤を若干加えたものを意味する。 操
作の便宜からいって水が最適であり、他の溶剤を使用す
るメリットは、とりたてて見当らない。The aqueous medium in which the reaction is carried out means water or water as a main component to which a small amount of an organic solvent such as methanol, ethanol or acetone is added. Water is most suitable for the convenience of operation, and the merit of using another solvent is not found.
【0025】[0025]
[実施例1]水21.8gに(RS)−α−メチルベンジ
ルアミン10g(82.5mmol)を溶解し、その溶液に
(R)−マンデル酸6.91g(45.4mmol)と35
%塩酸3.87g(37.1mmol)とを加えた。 さら
に、(R,R)−ビス(α−メチルベンジル)アミン塩酸
塩5.6mgを添加し、撹拌下に加熱して溶解させ、徐冷
ののち5℃まで冷却した。 ジアステレオマー塩(R)
−α−メチルベンジル・(R)−マンデル酸塩7.65
g(28.0mmol)が析出した。 この結晶は厚い六角
形で、濾過性の良好なものであった。[Example 1] 10 g (82.5 mmol) of (RS) -α-methylbenzylamine was dissolved in 21.8 g of water, and 6.91 g (45.4 mmol) of (R) -mandelic acid and 35
% Hydrochloric acid 3.87 g (37.1 mmol) was added. Further, (R, R) -bis (α-methylbenzyl) amine hydrochloride (5.6 mg) was added, and the mixture was heated with stirring to dissolve it, followed by gradual cooling and then cooling to 5 ° C. Diastereomeric salt (R)
-Α-Methylbenzyl. (R) -mandelate 7.65
g (28.0 mmol) was deposited. The crystals were thick hexagons and had good filterability.
【0026】反応液中に生成する難溶性ジアステレオマ
ー塩は、(RS)体の半量に当る(R)体分と分割剤と
を含めた11.27g(41.3mmol)のはずであるか
ら、(R,R)−ビス(α−メチルベンジル)アミン
は、この塩に対して0.05重量%添加したことにな
る。 また、共存していた塩は、(RS)体の残りと添
加した塩酸とで形成した塩酸塩(37.1mmol)である
から、その量は難溶性塩に対しては約90モル%であっ
たことになる。Since the sparingly soluble diastereomeric salt formed in the reaction solution should be 11.27 g (41.3 mmol) including the (R) component corresponding to half of the (RS) component and the resolving agent. , (R, R) -bis (α-methylbenzyl) amine was added in an amount of 0.05% by weight based on this salt. Also, the coexisting salt was the hydrochloride salt (37.1 mmol) formed by the rest of the (RS) form and the added hydrochloric acid, so the amount was about 90 mol% relative to the sparingly soluble salt. It will be.
【0027】上記の難溶性塩の収率は、使用した(R
S)体中の(R)体に対して68%であり、光学純度は
98.6%eeであった。(比旋光度+40.7゜/2
0℃) [実施例2]添加する(R,R)−ビス(α−メチルベ
ンジル)アミン塩酸塩の量を変えて、実施例1を繰り返
した。 同様な難溶性ジアステレオマー塩の結晶を得
た。The yields of the above-mentioned sparingly soluble salts were used (R
It was 68% based on the (R) form in the (S) form, and the optical purity was 98.6% ee. (Specific rotation + 40.7 ° / 2
0 ° C.) Example 2 Example 1 was repeated, varying the amount of (R, R) -bis (α-methylbenzyl) amine hydrochloride added. Crystals of a similar sparingly soluble diastereomeric salt were obtained.
【0028】[実施例3]添加するアミンとして(S,
S)−ビス(α−メチルベンジル)アミン(塩酸塩)を
光学分割剤として、(S)−マンデル酸をそれぞれ用い
て、実施例1と同様に操作した。 難溶性ジアステレオ
マ−塩(S)−α−メチルベンジルアミン・(S)−マ
ンデル酸塩が析出した。 実施例1と同様に、厚い六角
形の、濾過しやすい結晶が得られた。Example 3 As the amine to be added (S,
The same procedure as in Example 1 was carried out using (S) -bis (α-methylbenzyl) amine (hydrochloride) as an optical resolving agent and (S) -mandelic acid. The sparingly soluble diastereomer salt (S) -α-methylbenzylamine. (S) -mandelate salt was precipitated. As with Example 1, thick hexagonal crystals that were easy to filter were obtained.
【0029】[実施例4]ビス(α−メチルベンジル)
アミンとして(R,R)体と(S,S)体との等量混合
物を使用し、他の条件は実施例1と同様に操作した。
得られた難溶性ジアステレマー塩(R)−α−メチルベ
ンジルアミン・(R)−マンデル酸塩は、濾過しやすい
結晶であった。Example 4 Bis (α-methylbenzyl)
As the amine, an equal mixture of (R, R) and (S, S) isomers was used, and other conditions were the same as in Example 1.
The hardly soluble diasteremer salt (R) -α-methylbenzylamine. (R) -mandelate obtained was a crystal that was easily filtered.
【0030】[実施例5]添加するアミンを(R,S)
−ビス(α−メチルベンジル)アミンに変え、実施例1
を繰り返した。 大差ない結果が得られた。[Example 5] The added amine was (R, S).
-Bis (α-methylbenzyl) amine, Example 1
Was repeated. The result was not so different.
【0031】[実施例6]実施例1において、共存させ
る塩としてさらに塩化はナトリウムを、析出させようと
する難溶性ジアステレマー塩に対して120モル%加え
た形を実施した。菱形で、濾過性がきわめて良い結晶が
得られた。[Example 6] In Example 1, a form was carried out in which sodium chloride was further added as a coexisting salt in an amount of 120 mol% to the sparingly soluble diastereomer salt to be precipitated. Rhombic crystals with very good filterability were obtained.
【0032】[実施例7]実施例1で得た難溶性ジアス
テレチオマー塩(R)−α−メチルベンジルアミン・
(R)−マンデル酸塩10.4g(38.5mmol)を、
塩化ナトリウム0.23g(3.9mmol)とともに、水
89.4gに加熱下に溶解させた。 これに、(R,
R)ービス(α−メチルベンジル)アミン塩酸塩を5.
2mg(0.02mmol)添加した。 液を撹拌下に加熱
し、いったん溶解したのち冷却して難溶性ジアステレオ
マー塩を析出させた。Example 7 The sparingly soluble diastereomeric salt (R) -α-methylbenzylamine obtained in Example 1
10.4 g (38.5 mmol) of (R) -mandelate salt,
It was dissolved in 89.4 g of water with heating together with 0.23 g (3.9 mmol) of sodium chloride. In addition, (R,
R) -bis (α-methylbenzyl) amine hydrochloride was added to 5.
2 mg (0.02 mmol) was added. The liquid was heated with stirring, and once dissolved, it was cooled to precipitate a sparingly soluble diastereomeric salt.
【0033】得られた結晶は厚い六角形で、濾過性は良
好であった。 再結晶精製品は、収率76%光学純度9
8.6%eeであった。The obtained crystals were thick hexagons and had good filterability. The recrystallized product has a yield of 76% and an optical purity of 9
It was 8.6% ee.
【0034】[実施例8〜12]共存する塩をα−メチ
ルベンジルアミン塩酸塩以外の種々の塩に変え、そのほ
かは同様にして実施例7を繰り返した。 上記の各実施
例の操作条件および得られた結晶の形態を、表にまとめ
て示す。[Examples 8 to 12] Example 7 was repeated in the same manner except that the coexisting salt was changed to various salts other than α-methylbenzylamine hydrochloride. The operating conditions and the morphology of the crystals obtained in each of the above-mentioned examples are summarized in the table.
【0035】[比較例1〜5]つぎの態様で、(RS)
−α−メチルベンジルアミンの(R)−マンデル酸によ
る光学分割を実施した: 1)ビス(αーメチルベンジル)アミンを添加しない。 2)共存する塩がない。 3)添加剤として(S,S)−ビス(α−メチルベンジ
ル)アミン塩酸塩を使用する。 4)同じく添加剤として(R)−N−ベンジル−α−メ
チルベンジルアミン塩酸塩を使用する。 および 5)同じくジエチルアミン塩酸塩を使用する。[Comparative Examples 1 to 5] (RS)
Optical resolution of -α-methylbenzylamine with (R) -mandelic acid was carried out: 1) no bis (α-methylbenzyl) amine was added. 2) No coexisting salt. 3) Use (S, S) -bis (α-methylbenzyl) amine hydrochloride as an additive. 4) Similarly, (R) -N-benzyl-α-methylbenzylamine hydrochloride is used as an additive. And 5) also using diethylamine hydrochloride.
【0036】いずれも濾過性のよい難溶性塩の結晶を得
ることができなかった。 条件を、表にあわせて記載し
た。In all cases, it was not possible to obtain crystals of a sparingly soluble salt having good filterability. The conditions are shown in the table.
【0037】 表 No. 添加剤 濃 度 共存塩 濃 度 結晶 *1 重量% *2 モル% 形態 実施例 1 (R,R)−BαMBA 0.05 αMBA 90 B 2 (R,R)−BαMBA 0.007 αMBA 90 B 3 (S,S)−BαMBA 0.05 αMBA 90 B 4 (R,R)+(S,S) 0.05 αMBA 90 B −BαMBA 5 (R,S)−BαMBA 0.29 αMBA 90 B 6 (R,R)−BαMBA 0.05 塩化ナトリウム 120 C +αMBA 90 7 (R,R)−BαMBA 0.05 αMBA 10 B 8 (R,R)−BαMBA 0.05 塩化ナトリウム 10 B 9 (R,R)−BαMBA 0.05 ベンジルアミン 10 B 10 (R,R)−BαMBA 0.05 エチルアミン 10 B 11 (R,S)−BαMBA 0.05 塩化アンモニウム 10 B 12 (R,R)−BαMBA 0.05 酢酸アンモニウム 10 B 比較例 1 − − αMBA 90 A 2 (R,R)−BαMBA 0.05 − − A 3 (S,S)−BαMBA 1.00 αMBA 90 A 4 (R)−N−ベンジル− 2.18 αMBA 90
A α−メチルベンジルアミン 5 ジエチルアミン 0.20 αMBA 90 A *1 塩酸塩として添加した。 *2 アミンは塩酸
塩として存在させた。 BαMBA:ビス(α−メチルベンジル)アミン 結晶形態 A:長く薄い六角板状晶 B:六角晶 C:
菱形晶Table No. Additive Concentration Coexisting salt Concentration Crystal * 1 wt% * 2 mol% Embodiment Example 1 (R, R) -BαMBA 0.05 αMBA 90 B 2 (R, R) -BαMBA 0.007 αMBA 90 B 3 (S, S) -BαMBA 0.05 αMBA 90 B 4 (R, R) + (S, S) 0.05 αMBA 90 B -BαMBA 5 (R, S) -BαMBA 0.29 αMBA 90 B 6 (R, R) -BαMBA 0.05 Sodium chloride 120 C + αMBA 90 7 (R, R) -BαMBA 0.05 αMBA 10 B 8 (R, R) -BαMBA 0.05 Sodium chloride 10 B 9 (R, R) -BαMBA 0.05 Benzylamine 10 B 10 (R, R) -BαMBA 0.05 Ethylamine 10 B 11 (R, S) -BαMBA 0.05 Ammonium chloride 10 B 12 (R, R) -BαMBA 0.05 Ammonium acetate 10 B Comparative Example 1-αMBA 90 A 2 (R, R)- αMBA 0.05 - - A 3 (S, S) -BαMBA 1.00 αMBA 90 A 4 (R) -N- benzyl - 2.18 αMBA 90
A α-methylbenzylamine 5 diethylamine 0.20 αMBA 90 A * 1 Added as the hydrochloride salt. * 2 The amine was present as the hydrochloride salt. BαMBA: Bis (α-methylbenzyl) amine Crystal form A: Long and thin hexagonal plate crystal B: Hexagonal crystal C:
Rhombus
【0038】[0038]
【発明の効果】本発明の方法により光学活性α−メチル
ベンジルアミンを製造するときは、その過程で生成する
難溶性ジアステレオマー塩すなわち(R)−α−メチルベ
ンジルアミン・(R)−マンデル酸塩および(S)−α
−メチルベンジル・(S)−マンデル酸塩が、通常みら
れる長く薄い六角板状晶でなく、六角晶、さらに反応条
件によっては菱形晶として得られる。 これらの結晶は
濾過性が良好であって、遠心分離機を用いた固液分離に
当って母液の「きれ」がよく、かつケークの洗浄が効果
的に行なえるから、不要の対掌体をほとんど含まないジ
アステレオマー塩を取得することができる。 この利益
は、難溶性ジアステレオマー塩の水性媒体からの再結晶
精製においても得られる。INDUSTRIAL APPLICABILITY When the optically active α-methylbenzylamine is produced by the method of the present invention, a sparingly soluble diastereomeric salt formed in the process, that is, (R) -α-methylbenzylamine. (R) -mandel Acid salt and (S) -α
The -methylbenzyl. (S) -mandelate salt is obtained as a hexagonal crystal and, depending on the reaction conditions, a rhomboidal crystal, instead of the usual long and thin hexagonal plate crystal. These crystals have good filterability, the mother liquor “breaks” well during solid-liquid separation using a centrifuge, and the cake can be effectively washed. It is possible to obtain a diastereomeric salt that is almost free. This benefit is also obtained in recrystallisation purification of sparingly soluble diastereomeric salts from aqueous media.
【0039】従って本発明により、高い光学純度をもっ
た光学活性α−メチルベンジルアミンの需要に対して、
コストを高くすることなく応じることが可能である。Therefore, according to the present invention, in response to the demand for optically active α-methylbenzylamine having high optical purity,
It is possible to respond without increasing the cost.
【手続補正書】[Procedure amendment]
【提出日】平成4年9月4日[Submission date] September 4, 1992
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0018[Correction target item name] 0018
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0018】ビス(α−メチルベンジル)アミンは、前
記したように、目的物に応じて、立体配置が(R,R)ま
たは(S,S)を使用するのが有利であり、難溶性ジアス
テレオマー塩に対して重量で0.005%以上あれば有
効である。 (R,S)または(S,R)であらわされ
るものは目的物がどちらであっても使用できるが、難溶
性ジアステレオマー塩に対して0.2重量%程度の存在
を必要とする。 ビス(α−メチルベンジル)アミンが
目的物と立体配置に関して同じ構成部分をもっていない
場合は、1重量%を添加しても、期待した効果を得るこ
とができない。As described above, the bis (α-methylbenzyl) amine is advantageous in that the steric configuration is (R, R) or (S, S) depending on the intended product. It is effective if the weight is 0.005% or more based on the stereomeric salt. The compound represented by (R, S) or (S, R) can be used regardless of the intended product, but it needs to be present in an amount of about 0.2% by weight based on the sparingly soluble diastereomeric salt. When bis (α-methylbenzyl) amine does not have the same constitutional portion with respect to the target compound in terms of configuration, the expected effect cannot be obtained even if 1% by weight is added.
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0033[Correction target item name] 0033
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0033】得られた結晶は厚い六角形で、濾過性は良
好であった。 再結晶精製品は、収率76%光学純度1
00%eeであった。The obtained crystals were thick hexagons and had good filterability. The recrystallized product has a yield of 76% and an optical purity of 1.
It was 00% ee.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 野平 博之 埼玉県浦和市大久保領家51番5号 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Hiroyuki Nohira 51-5 Ryoke Okubo, Urawa City, Saitama Prefecture
Claims (4)
らジアステレオマー法により(R)−または(S)−α
−メチルベンジルアミンを製造する方法において、水性
媒体中で、(RS)−α−メチルベンジルアミンに対
し、式(I)であらわされるビス(α−メチルベンジ
ル)アミン 【化1】 ならびに、アンモニアもしくは一級アミンの無機酸もし
くは有機酸の塩および(または)水溶性無機塩類の存在
下に、分割剤として光学活性マンデル酸を作用させ、式
(II)であらわされる難溶性の光学活性ジアステレオマ
ー塩 【化2】 (式中、*は不斉炭素原子をあらわす。)を濾過容易な
結晶として析出させることを特徴とする光学活性α−メ
チルベンジルアミンの製造方法。1. An (R)-or (S) -α from (RS) -α-methylbenzylamine by a diastereomeric method.
In the method for producing methylbenzylamine, bis (α-methylbenzyl) amine represented by the formula (I) is used for (RS) -α-methylbenzylamine in an aqueous medium. In addition, an optically active mandelic acid is allowed to act as a resolving agent in the presence of a salt of an inorganic acid or an organic acid of ammonia or a primary amine and / or a water-soluble inorganic salt, and the sparingly soluble optical activity represented by the formula (II) is obtained. Diastereomeric salt (In the formula, * represents an asymmetric carbon atom.) The method for producing an optically active α-methylbenzylamine, which comprises depositing crystals as crystals that are easy to filter.
使用し、式(I)であらわされるビス(α−メチルベン
ジル)アミンとして立体配置が(R,R)または(R,
S)であるものを存在させ、式(II)であらわされる難
溶性ジアステレオマー塩として(R)−α−メチルベン
ジルアミン・(R)−マンデル酸塩を形成させる請求項
1の製造方法。2. An (R) -mandelic acid is used as an optical resolving agent, and a bis (α-methylbenzyl) amine represented by the formula (I) has a configuration of (R, R) or (R, R).
S) is present to form (R) -α-methylbenzylamine. (R) -mandelate as the sparingly soluble diastereomeric salt of formula (II).
使用し、式(I)であらわされるビス(α−メチルベン
ジル)アミンとして立体配置が(S,S)または(R,
S)であるものを存在させ、式(II)であらわされる難
溶性ジアステレオマー塩として(S)−α−メチルベン
ジルアミン・(S)−マンデル酸塩を形成させる請求項
1の製造方法。3. A (S) -mandelic acid is used as an optical resolving agent, and a bis (α-methylbenzyl) amine represented by the formula (I) has a configuration of (S, S) or (R,
S) is present to form (S) -α-methylbenzylamine. (S) -mandelate as the sparingly soluble diastereomeric salt of formula (II).
光学活性ジアステレオマ−塩を、前記の式(I)であら
わされるビス(α−メチルベンジル)アミン、ならび
に、アンモニアもしくは一級アミンの無機酸もしくは有
機酸の塩および(または)水溶性無機塩類の存在する水
性媒体から再結晶させ、光学活性ジアステレオマー塩を
濾過容易な結晶として析出させることを特徴とする光学
活性α−メチルベンジルアミンの製造方法。4. A sparingly soluble optically active diastereomer salt represented by the above formula (II) is converted into a bis (α-methylbenzyl) amine represented by the above formula (I) and an inorganic substance of ammonia or a primary amine. An optically active α-methylbenzylamine characterized by being recrystallized from an aqueous medium in which a salt of an acid or an organic acid and / or a water-soluble inorganic salt is present to precipitate an optically active diastereomer salt as a crystal which is easily filtered. Manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15835692A JP3178086B2 (en) | 1992-06-17 | 1992-06-17 | Method for producing optically active α-methylbenzylamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15835692A JP3178086B2 (en) | 1992-06-17 | 1992-06-17 | Method for producing optically active α-methylbenzylamine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH061757A true JPH061757A (en) | 1994-01-11 |
JP3178086B2 JP3178086B2 (en) | 2001-06-18 |
Family
ID=15669880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15835692A Expired - Fee Related JP3178086B2 (en) | 1992-06-17 | 1992-06-17 | Method for producing optically active α-methylbenzylamine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3178086B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504253A (en) * | 1994-07-15 | 1996-04-02 | Nps Pharmaceuticals, Inc. | Amine preparation |
WO2007088571A2 (en) * | 2006-02-02 | 2007-08-09 | Abiogen Pharma S.P.A. | A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest |
JP2009138002A (en) * | 1997-09-11 | 2009-06-25 | Pharmacia & Upjohn Co Llc | Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors |
-
1992
- 1992-06-17 JP JP15835692A patent/JP3178086B2/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504253A (en) * | 1994-07-15 | 1996-04-02 | Nps Pharmaceuticals, Inc. | Amine preparation |
US5633404A (en) * | 1994-07-15 | 1997-05-27 | Nps Pharmaceuticals, Inc. | N-((R)-α-methyl-3-methoxybenzyl)-3-(2-chlorobenzene)propanamide |
JP2009138002A (en) * | 1997-09-11 | 2009-06-25 | Pharmacia & Upjohn Co Llc | Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors |
WO2007088571A2 (en) * | 2006-02-02 | 2007-08-09 | Abiogen Pharma S.P.A. | A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest |
WO2007088571A3 (en) * | 2006-02-02 | 2008-01-10 | Abiogen Pharma Spa | A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest |
US7968748B2 (en) | 2006-02-02 | 2011-06-28 | Abiogen Pharma S.P.A. | Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest |
Also Published As
Publication number | Publication date |
---|---|
JP3178086B2 (en) | 2001-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4545945B2 (en) | Production of iodixanol | |
JPH061757A (en) | Production of optically active alpha-methylbenzylamine | |
JPS6340180B2 (en) | ||
DE69501705T2 (en) | Process for the preparation of optically active piperazine derivatives and intermediates for their manufacture | |
DE69302879T2 (en) | Process for the optical separation of (+) - cis-4-aminocyclopent-2-en-1-carboxylic acid derivatives | |
JP2830364B2 (en) | Method for producing optically active 1-benzyl-3-hydroxypyrrolidine | |
JP3663643B2 (en) | Process for producing optically active 1- (2,4-dichlorophenyl) ethylamine | |
JPH05279325A (en) | Production of optically active 3-hydroxypyrolidine | |
JP3304419B2 (en) | Method for producing optically active 1- (4-halogenophenyl) ethylamine | |
JP3080801B2 (en) | Taurine purification method | |
JP3738470B2 (en) | Process for producing optically active 1- (dichloro-substituted phenyl) ethylamines | |
JPS61501704A (en) | Method for producing optically active phenylalanine and their N-acyl derivatives and novel diastereomeric salts of these compounds | |
JPS5980627A (en) | Optical resolution of alpha-isopropyl-p-chlorophenylacetic acid | |
JP4380325B2 (en) | Process for producing optically active carboxylic acid | |
JPH10101629A (en) | Production of optically active butyric acid derivative | |
JPH0325416B2 (en) | ||
JP3694923B2 (en) | Process for producing optically active 1- (2,4-dichlorophenyl) ethylamine | |
JP3157117B2 (en) | Optical resolution method of piperidine derivative | |
JP3316917B2 (en) | New phenylalanine salt crystals and their production | |
JPH06107603A (en) | Production of optically active 1-phenylethylamine derivative | |
JPH08183779A (en) | Production of optically active piperazine derivative and intermediate for production | |
JPH09143128A (en) | Production of optically active 1-phenylethylamine | |
JPH03279375A (en) | Resolution of optically active 2-methylpiperazine | |
JP2004051604A (en) | Production method of optically active 2-amino-2-(2-naphthyl)ethanols and intermediate thereof | |
JPS59231065A (en) | Novel propionic acid derivative salt and optical resolution of propionic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |